BMI Patterns in ILD Outcomes Examined - Summary - MDSpire

BMI Patterns in ILD Outcomes Examined

Meta-analysis links higher body mass index to lower mortality and slower lung function decline in interstitial lung disease

  • By

  • Kathryn Wighton

  • April 1, 2026

  • 3 min

Share

Objective:

To evaluate the association between body mass index (BMI) and clinical outcomes in patients with interstitial lung disease (ILD).

Key Findings:
  • Include context on statistical significance.
Interpretation:

BMI serves as a marker of overall health status in ILD patients, rather than a direct therapeutic target.

Limitations:
  • Mention the impact of publication bias.
Conclusion:

Reiterate implications of BMI as a health marker.

Original Source(s)

BMI Patterns in ILD Outcomes Examined

  • by Kathryn Wighton

  • April 1, 2026

Related Content

Sex Disparities May Persist in CF Despite Modulators

Review findings suggested female patients with cystic fibrosis may continue to experience worse pulmonary outcomes despite highly effective modulator therapy

FDA Approves Expanded Liquid Biopsy Panel

Updated liquid biopsy combines genomic and epigenomic profiling for companion diagnostic use across multiple tumor types.

Impact of diabetes mellitus on mortality in patients with acute exacerbation of chronic obstructive Pulmonary disease: a meta-analysis and systematic review